135 related articles for article (PubMed ID: 33459500)
1. Female reproductive function after treatment of childhood acute lymphoblastic leukemia.
Roshandel R; van Dijk M; Overbeek A; Kaspers G; Lambalk C; Beerendonk C; Bresters D; van der Heiden-van der Loo M; van den Heuvel-Eibrink M; Kremer L; Loonen J; van der Pal H; Ronckers C; Tissing W; Versluys B; van Leeuwen F; van den Berg M; van Dulmen-den Broeder E;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28894. PubMed ID: 33459500
[TBL] [Abstract][Full Text] [Related]
2. Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: a review.
Drechsel KCE; Pilon MCF; Stoutjesdijk F; Meivis S; Schoonmade LJ; Wallace WHB; van Dulmen-den Broeder E; Beishuizen A; Kaspers GJL; Broer SL; Veening MA
Hum Reprod Update; 2023 Jul; 29(4):486-517. PubMed ID: 36779325
[TBL] [Abstract][Full Text] [Related]
3. Ovarian function in female survivors of childhood malignancies.
El-Shalakany AH; Ali MS; Abdelmaksoud AA; Abd El-Ghany S; Hasan EA
Pediatr Hematol Oncol; 2013 May; 30(4):328-35. PubMed ID: 23574301
[TBL] [Abstract][Full Text] [Related]
4. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
Molgaard-Hansen L; Skou AS; Juul A; Glosli H; Jahnukainen K; Jarfelt M; Jónmundsson GK; Malmros J; Nysom K; Hasle H;
Pediatr Blood Cancer; 2013 Dec; 60(12):1988-95. PubMed ID: 24038890
[TBL] [Abstract][Full Text] [Related]
5. Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia.
Elitzur S; Frank S; Goshen-Lago T; Barzilai-Birenboim S; Gilad G; Avrahami G; Goldberg T; Litichever N; Masarwa A; Oron G; Yaniv I; Izraeli S; Ben-Aharon I
Leuk Lymphoma; 2021 Sep; 62(9):2211-2218. PubMed ID: 33749493
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
[TBL] [Abstract][Full Text] [Related]
7. The influence of different intensity of treatment on hormonal markers of gonadal function in acute lymphoblastic leukemia survivors.
Krawczuk-Rybak M; Płonowski M; Leszczyńska E; Latoch E; Sawicka-Żukowska M; Muszyńska-Rosłan K; Skalska-Sadowska J; Wachowiak J; Sga-Pondel D; Kazanowska B; Chybicka A; Stachowicz-Stencel T; Stefanowicz J; Malinowska I; Matysiak M; Kotan A; Wysocki M; Pobudejska-Pieniążek A; Szczepański T; Przybyszewski B; Badowska W; Szymańska-Miller D; Kowalczyk JR; Kamieńska E; Urasiński T; Wawrzeńczyk A; Żelazowska-Rutkowska B; Cylwik B
Hematol Oncol; 2019 Dec; 37(5):609-616. PubMed ID: 31523837
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
9. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
10. FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women.
Rull K; Grigorova M; Ehrenberg A; Vaas P; Sekavin A; Nõmmemees D; Adler M; Hanson E; Juhanson P; Laan M
Hum Reprod; 2018 May; 33(5):954-966. PubMed ID: 29617818
[TBL] [Abstract][Full Text] [Related]
11. Clinical and self-reported markers of reproductive function in female survivors of childhood Hodgkin lymphoma.
Drechsel KCE; Broer SL; Stoutjesdijk FS; Twisk JWR; van den Berg MH; Lambalk CB; van Leeuwen FE; Overbeek A; van den Heuvel-Eibrink MM; van Dorp W; de Vries ACH; Loonen JJ; van der Pal HJ; Kremer LC; Tissing WJ; Versluys B; Kaspers GJL; van Dulmen-den Broeder E; Veening MA;
J Cancer Res Clin Oncol; 2023 Nov; 149(15):13677-13695. PubMed ID: 37522923
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
Nies M; Cantineau AEP; Arts EGJM; van den Berg MH; van Leeuwen FE; Muller Kobold AC; Klein Hesselink MS; Burgerhof JGM; Brouwers AH; van Dam EWCM; Havekes B; van den Heuvel-Eibrink MM; Corssmit EPM; Kremer LCM; Netea-Maier RT; van der Pal HJH; Peeters RP; Plukker JTM; Ronckers CM; van Santen HM; van der Horst-Schrivers ANA; Tissing WJE; Bocca G; van Dulmen-den Broeder E; Links TP
Thyroid; 2020 Aug; 30(8):1169-1176. PubMed ID: 32079487
[No Abstract] [Full Text] [Related]
13. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
14. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy after cancer: results from a prospective cohort study of cancer survivors.
Dillon KE; Sammel MD; Ginsberg JP; Lechtenberg L; Prewitt M; Gracia CR
Pediatr Blood Cancer; 2013 Dec; 60(12):2001-6. PubMed ID: 24038829
[TBL] [Abstract][Full Text] [Related]
16. Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors.
Salih SM; Elsarrag SZ; Prange E; Contreras K; Osman RG; Eikoff JC; Puccetti D
J Pediatr Adolesc Gynecol; 2015 Apr; 28(2):95-101. PubMed ID: 25850590
[TBL] [Abstract][Full Text] [Related]
17. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
[TBL] [Abstract][Full Text] [Related]
18. Reproductive intentions and use of reproductive health care among female survivors of childhood cancer.
van Dijk M; van den Berg MH; Overbeek A; Lambalk CB; van den Heuvel-Eibrink MM; Tissing WJ; Kremer LC; van der Pal HJ; Loonen JJ; Versluys B; Bresters D; Kaspers GJL; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Jun; 33(6):1167-1174. PubMed ID: 29617794
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
20. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
